YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2D325F082G
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $81,735
Award facts
- Contract value 100% obligated
- $81,734.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, has been awarded a delivery order valued at $81,734.80 for YF-VAX 1 Dose Vials. This firm fixed-price delivery order was issued by the Defense Logistics Agency's Medical Supply Chain division on May 27, 2025, with an ultimate completion date of May 30, 2025. The contract carries no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) within the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
YF-VAX, a yellow fever vaccine, represents one of numerous pharmaceutical and biologic products within DMS Pharmaceutical Group's extensive product portfolio supplied to the federal government. The company has demonstrated substantial performance across multiple delivery orders ranging from under $100 to exceeding $115,000, supplying branded and generic prescription medications, over-the-counter drugs, specialty pharmaceuticals, biologics, and medical consumables. This delivery order aligns with DMS Pharmaceutical Group's established role as a critical pharmaceutical supplier supporting recurring medical supply needs of military healthcare operations, with the underlying IDC structured to enable continued supply of diverse and specialized pharmaceutical requirements through December 31, 2036.
Quick answers
Who was awarded contract SPE2D325F082G?
SPE2D325F082G was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on May 27, 2025.
How much is contract SPE2D325F082G worth?
The government has obligated $81,735 on SPE2D325F082G.
Is contract SPE2D325F082G an order under another contract?
Yes. SPE2D325F082G is a delivery order under SPE2D021DA002, an indefinite delivery contract.
Was contract SPE2D325F082G competed?
The extent of competition for SPE2D325F082G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award